Biopharmaceutical player Biocon to acquire 26% stake in AMPYR Renewable Energy Resources Eleven for solar power
In its regulatory filing on Wednesday, Biocon said, “we wish to inform you that the Company has entered into an agreement for the purpose of acquisition of solar power by